Absci and AstraZeneca Sign $247M Partnership for AI-Powered Drug Discovery to Fight Cancer
Absci Corporation (ABSI) and AstraZeneca announced a collaboration today to develop an AI-designed antibody for cancer.
Stay updated with breaking news from Pm Partnership. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Absci Corporation (ABSI) and AstraZeneca announced a collaboration today to develop an AI-designed antibody for cancer.
News from the Seacoast business community.
Red Hat CEO Paul Cormier talks hybrid multicloud, GM partnership, IBM and the future of hardware - SiliconANGLE
/PRNewswire/ -- The "Mobile Payments Market by Technology (SMS, Beacon, NFC), Location (Proximity and Remote), Device (Smartphone, Wearable, Implantable,...
/PRNewswire/ -- The "Mobile Payments Market by Technology (SMS, Beacon, NFC), Location (Proximity and Remote), Device (Smartphone, Wearable, Implantable,...